Table 2.
Placebo % | Bupropion % | |
---|---|---|
Insomniaa | 9–21 | 24–42 |
Headache | 3–33 | 4–33 |
Dry mouthb | 4–24 | 6–28 |
Rash/Pruritus | 7 | 15 |
Rhinitis | 12–17 | 10–14 |
Nausea/Vomiting | 5–6 | 9–13 |
Dizziness | 1–6 | 2–11 |
Anxiety | 5–11 | 5–9 |
Flu syndrome | 6–11 | 4–9 |
Taste perversion | 5 | 6 |
Constipation | 1 | 5–6 |
Sweating | 3 | 5 |
Mood disorder | 4 | 4 |
Statistical significance demonstrated in 4 trials (Hurt et al 1997;Jorenby et al 1999; Ahluwalia et al 2002; Dalsgard et al 2004).
Statistical significance demonstrated in 2 trials (Hurt et al 1997; Jorenby et al 1999).